Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients

Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients

Introduction: The whole world is on the brink of collapse due to the outbreak of COVID-19 with no solution to treat these cases with any specific drug. Extensive search for the Vaccine or effective treatment is going on while alarming infection and death toll is rising every day. Aim: The study will...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Bangladesh College of Physicians & Surgeons 2020-07, Vol.38, p.5-9
Hauptverfasser: Rahman, Md Azizur, Iqbal, Syed Asif, Islam, Md Azizul, Niaz, Md Kaisar, Hussain, Tahmeed, Siddiquee, Taufiqul Hasan
Format: Artikel
Sprache:eng
Schlagworte:
COVID-19
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9
container_issue
container_start_page 5
container_title Journal of Bangladesh College of Physicians & Surgeons
container_volume 38
creator Rahman, Md Azizur
Iqbal, Syed Asif
Islam, Md Azizul
Niaz, Md Kaisar
Hussain, Tahmeed
Siddiquee, Taufiqul Hasan
description Introduction: The whole world is on the brink of collapse due to the outbreak of COVID-19 with no solution to treat these cases with any specific drug. Extensive search for the Vaccine or effective treatment is going on while alarming infection and death toll is rising every day. Aim: The study will compare the effect of Ivermectin with Doxycycline and Hydoxychloroquine with Azythromicin on a selective group of COVID -19 positive patients. Method: This is a comparative study that included 400 patients of COVID 19 positive patient who were divided in to two groups. Group- A Received Ivermectin with Doxycycline and the other group- B received hydroxichloroquine(HCQ) with azithromycin. Result: Viral clearance is 132 ( 66%) on day 5 and 167( 83.5% ) on day 6. Among them 33(16.5%) remain PCR positive after 6th day of Ivermectin ingestion in Group A. Whereas there is154 ( 77.0%) viral clearance at 11th day and 163(81.5%) viral clearance at 12th day of Hydroxychloroquine ingestion in Group B. Among them 37 (18.5%) remain PCR positive after 12 day in group B. The P value is 0.000427 which is significant considering 5th day viral clearance of Ivermectin ingestion and 11th day of Hydroxychloroquine ingestion. But considering 6th day and 12th day the P-value is 0.59 which is not significant. Conclusion: It appears Ivermectin and Doxycycline is safeand effective combination drug therapy in COVID- 19infected patients but need further extensive study to find out the scope of application on other groups of patients. J Bangladesh Coll Phys Surg 2020; 38(0): 5-9
doi_str_mv 10.3329/jbcps.v38i0.47514
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3112823738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3112823738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1188-1c74d13a2635bebb556708af1edaf2248ac2b170b696fff05f16290d73d320683</originalsourceid><addsrcrecordid>eNotkF1LwzAUhoMoOOZ-gHcBrztzkiZtL0enbjCYF7rbkqYJ62ibmXSb9ca_btt5OJwDL-_54EHoEcicMZo8H3J19PMzi0syDyMO4Q2aUEaSQDDBb9EECPCAxBG5RzPvD6QPBiFnfIJ-U1sfpSu9bbA1eFc6WeG00tLJRmmc6_aidYPXZ-1qrdqywZey3eOl_e5Up6qy0Vg2BV51hRukfWWd_ToN8uhb_PTV2bpT_WSf6Xa3XgaQ4HfZlrpp_QO6M7Lyevbfp-jz9eUjXQWb7ds6XWwCBRDHAagoLIBJKhjPdZ5zLiISSwO6kIbSMJaK5hCRXCTCGEO4AUETUkSsYJSImE3R03XvcfhP-zY72JNr-pMZA6AxZREbXHB1KWe9d9pkR1fW0nUZkGxAnY2osxF1NqJmf4WHdJ0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3112823738</pqid></control><display><type>article</type><title>Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients</title><source>Bangladesh Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Rahman, Md Azizur ; Iqbal, Syed Asif ; Islam, Md Azizul ; Niaz, Md Kaisar ; Hussain, Tahmeed ; Siddiquee, Taufiqul Hasan</creator><creatorcontrib>Rahman, Md Azizur ; Iqbal, Syed Asif ; Islam, Md Azizul ; Niaz, Md Kaisar ; Hussain, Tahmeed ; Siddiquee, Taufiqul Hasan</creatorcontrib><description>Introduction: The whole world is on the brink of collapse due to the outbreak of COVID-19 with no solution to treat these cases with any specific drug. Extensive search for the Vaccine or effective treatment is going on while alarming infection and death toll is rising every day. Aim: The study will compare the effect of Ivermectin with Doxycycline and Hydoxychloroquine with Azythromicin on a selective group of COVID -19 positive patients. Method: This is a comparative study that included 400 patients of COVID 19 positive patient who were divided in to two groups. Group- A Received Ivermectin with Doxycycline and the other group- B received hydroxichloroquine(HCQ) with azithromycin. Result: Viral clearance is 132 ( 66%) on day 5 and 167( 83.5% ) on day 6. Among them 33(16.5%) remain PCR positive after 6th day of Ivermectin ingestion in Group A. Whereas there is154 ( 77.0%) viral clearance at 11th day and 163(81.5%) viral clearance at 12th day of Hydroxychloroquine ingestion in Group B. Among them 37 (18.5%) remain PCR positive after 12 day in group B. The P value is 0.000427 which is significant considering 5th day viral clearance of Ivermectin ingestion and 11th day of Hydroxychloroquine ingestion. But considering 6th day and 12th day the P-value is 0.59 which is not significant. Conclusion: It appears Ivermectin and Doxycycline is safeand effective combination drug therapy in COVID- 19infected patients but need further extensive study to find out the scope of application on other groups of patients. J Bangladesh Coll Phys Surg 2020; 38(0): 5-9</description><identifier>ISSN: 1015-0870</identifier><identifier>EISSN: 2309-6365</identifier><identifier>DOI: 10.3329/jbcps.v38i0.47514</identifier><language>eng</language><publisher>Dhaka: Bangladesh College of Physicians &amp; Surgeons</publisher><subject>COVID-19</subject><ispartof>Journal of Bangladesh College of Physicians &amp; Surgeons, 2020-07, Vol.38, p.5-9</ispartof><rights>Copyright Bangladesh College of Physicians &amp; Surgeons 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1188-1c74d13a2635bebb556708af1edaf2248ac2b170b696fff05f16290d73d320683</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4125,27924,27925</link.rule.ids></links><search><creatorcontrib>Rahman, Md Azizur</creatorcontrib><creatorcontrib>Iqbal, Syed Asif</creatorcontrib><creatorcontrib>Islam, Md Azizul</creatorcontrib><creatorcontrib>Niaz, Md Kaisar</creatorcontrib><creatorcontrib>Hussain, Tahmeed</creatorcontrib><creatorcontrib>Siddiquee, Taufiqul Hasan</creatorcontrib><title>Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients</title><title>Journal of Bangladesh College of Physicians &amp; Surgeons</title><description>Introduction: The whole world is on the brink of collapse due to the outbreak of COVID-19 with no solution to treat these cases with any specific drug. Extensive search for the Vaccine or effective treatment is going on while alarming infection and death toll is rising every day. Aim: The study will compare the effect of Ivermectin with Doxycycline and Hydoxychloroquine with Azythromicin on a selective group of COVID -19 positive patients. Method: This is a comparative study that included 400 patients of COVID 19 positive patient who were divided in to two groups. Group- A Received Ivermectin with Doxycycline and the other group- B received hydroxichloroquine(HCQ) with azithromycin. Result: Viral clearance is 132 ( 66%) on day 5 and 167( 83.5% ) on day 6. Among them 33(16.5%) remain PCR positive after 6th day of Ivermectin ingestion in Group A. Whereas there is154 ( 77.0%) viral clearance at 11th day and 163(81.5%) viral clearance at 12th day of Hydroxychloroquine ingestion in Group B. Among them 37 (18.5%) remain PCR positive after 12 day in group B. The P value is 0.000427 which is significant considering 5th day viral clearance of Ivermectin ingestion and 11th day of Hydroxychloroquine ingestion. But considering 6th day and 12th day the P-value is 0.59 which is not significant. Conclusion: It appears Ivermectin and Doxycycline is safeand effective combination drug therapy in COVID- 19infected patients but need further extensive study to find out the scope of application on other groups of patients. J Bangladesh Coll Phys Surg 2020; 38(0): 5-9</description><subject>COVID-19</subject><issn>1015-0870</issn><issn>2309-6365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNotkF1LwzAUhoMoOOZ-gHcBrztzkiZtL0enbjCYF7rbkqYJ62ibmXSb9ca_btt5OJwDL-_54EHoEcicMZo8H3J19PMzi0syDyMO4Q2aUEaSQDDBb9EECPCAxBG5RzPvD6QPBiFnfIJ-U1sfpSu9bbA1eFc6WeG00tLJRmmc6_aidYPXZ-1qrdqywZey3eOl_e5Up6qy0Vg2BV51hRukfWWd_ToN8uhb_PTV2bpT_WSf6Xa3XgaQ4HfZlrpp_QO6M7Lyevbfp-jz9eUjXQWb7ds6XWwCBRDHAagoLIBJKhjPdZ5zLiISSwO6kIbSMJaK5hCRXCTCGEO4AUETUkSsYJSImE3R03XvcfhP-zY72JNr-pMZA6AxZREbXHB1KWe9d9pkR1fW0nUZkGxAnY2osxF1NqJmf4WHdJ0</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Rahman, Md Azizur</creator><creator>Iqbal, Syed Asif</creator><creator>Islam, Md Azizul</creator><creator>Niaz, Md Kaisar</creator><creator>Hussain, Tahmeed</creator><creator>Siddiquee, Taufiqul Hasan</creator><general>Bangladesh College of Physicians &amp; Surgeons</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20200701</creationdate><title>Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients</title><author>Rahman, Md Azizur ; Iqbal, Syed Asif ; Islam, Md Azizul ; Niaz, Md Kaisar ; Hussain, Tahmeed ; Siddiquee, Taufiqul Hasan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1188-1c74d13a2635bebb556708af1edaf2248ac2b170b696fff05f16290d73d320683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>COVID-19</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahman, Md Azizur</creatorcontrib><creatorcontrib>Iqbal, Syed Asif</creatorcontrib><creatorcontrib>Islam, Md Azizul</creatorcontrib><creatorcontrib>Niaz, Md Kaisar</creatorcontrib><creatorcontrib>Hussain, Tahmeed</creatorcontrib><creatorcontrib>Siddiquee, Taufiqul Hasan</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of Bangladesh College of Physicians &amp; Surgeons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahman, Md Azizur</au><au>Iqbal, Syed Asif</au><au>Islam, Md Azizul</au><au>Niaz, Md Kaisar</au><au>Hussain, Tahmeed</au><au>Siddiquee, Taufiqul Hasan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients</atitle><jtitle>Journal of Bangladesh College of Physicians &amp; Surgeons</jtitle><date>2020-07-01</date><risdate>2020</risdate><volume>38</volume><spage>5</spage><epage>9</epage><pages>5-9</pages><issn>1015-0870</issn><eissn>2309-6365</eissn><abstract>Introduction: The whole world is on the brink of collapse due to the outbreak of COVID-19 with no solution to treat these cases with any specific drug. Extensive search for the Vaccine or effective treatment is going on while alarming infection and death toll is rising every day. Aim: The study will compare the effect of Ivermectin with Doxycycline and Hydoxychloroquine with Azythromicin on a selective group of COVID -19 positive patients. Method: This is a comparative study that included 400 patients of COVID 19 positive patient who were divided in to two groups. Group- A Received Ivermectin with Doxycycline and the other group- B received hydroxichloroquine(HCQ) with azithromycin. Result: Viral clearance is 132 ( 66%) on day 5 and 167( 83.5% ) on day 6. Among them 33(16.5%) remain PCR positive after 6th day of Ivermectin ingestion in Group A. Whereas there is154 ( 77.0%) viral clearance at 11th day and 163(81.5%) viral clearance at 12th day of Hydroxychloroquine ingestion in Group B. Among them 37 (18.5%) remain PCR positive after 12 day in group B. The P value is 0.000427 which is significant considering 5th day viral clearance of Ivermectin ingestion and 11th day of Hydroxychloroquine ingestion. But considering 6th day and 12th day the P-value is 0.59 which is not significant. Conclusion: It appears Ivermectin and Doxycycline is safeand effective combination drug therapy in COVID- 19infected patients but need further extensive study to find out the scope of application on other groups of patients. J Bangladesh Coll Phys Surg 2020; 38(0): 5-9</abstract><cop>Dhaka</cop><pub>Bangladesh College of Physicians &amp; Surgeons</pub><doi>10.3329/jbcps.v38i0.47514</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1015-0870
ispartof Journal of Bangladesh College of Physicians & Surgeons, 2020-07, Vol.38, p.5-9
issn 1015-0870
2309-6365
language eng
recordid cdi_proquest_journals_3112823738
source Bangladesh Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects COVID-19
title Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A21%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Viral%20Clearance%20between%20Ivermectin%20with%20Doxycycline%20and%20Hydroxychloroquine%20with%20Azithromycin%20in%20COVID-19%20Patients&rft.jtitle=Journal%20of%20Bangladesh%20College%20of%20Physicians%20&%20Surgeons&rft.au=Rahman,%20Md%20Azizur&rft.date=2020-07-01&rft.volume=38&rft.spage=5&rft.epage=9&rft.pages=5-9&rft.issn=1015-0870&rft.eissn=2309-6365&rft_id=info:doi/10.3329/jbcps.v38i0.47514&rft_dat=%3Cproquest_cross%3E3112823738%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3112823738&rft_id=info:pmid/&rfr_iscdi=true